Literature DB >> 22274413

Long-term effects of systemic cancer treatment on DNA oxidative damage: the potential for targeted therapies.

Laura Vera-Ramirez1, McArmen Ramirez-Tortosa, Patricia Perez-Lopez, Sergio Granados-Principal, Maurizio Battino, José L Quiles.   

Abstract

The main pathological consequence of free radical exposure is DNA damage, which is known to induce cell transformation and to facilitate important mutations in cancer progression. It is a matter of intense discussion whether the drug-induced production of free radicals limits the therapeutic efficacy of chemotherapeutics and enhances their toxicity or whether they may be enhanced to provoke cancer cell apoptosis. This paper reviews essential molecular processes to better understand the controversial role of free radicals in cancer development and progression, and discusses some novel therapeutic strategies based on oxidative stress induction and prevention.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274413     DOI: 10.1016/j.canlet.2011.12.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity.

Authors:  Hani A Al-Shobaili; Abdullateef A Alzolibani; Ahmad A Al Robaee; Abdel-Raheim M A Meki; Zafar Rasheed
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

2.  Tempol prevents genotoxicity induced by vorinostat: role of oxidative DNA damage.

Authors:  Karem H Alzoubi; Omar F Khabour; Aya G Jaber; Sayer I Al-Azzam; Nizar M Mhaidat; Majed M Masadeh
Journal:  Cytotechnology       Date:  2013-06-13       Impact factor: 2.058

Review 3.  Oxidative Stress in Cancer Cell Metabolism.

Authors:  Saniya Arfin; Niraj Kumar Jha; Saurabh Kumar Jha; Kavindra Kumar Kesari; Janne Ruokolainen; Shubhadeep Roychoudhury; Brijesh Rathi; Dhruv Kumar
Journal:  Antioxidants (Basel)       Date:  2021-04-22

4.  The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.

Authors:  Elke Tatjana Aristizabal Prada; Michael Orth; Svenja Nölting; Gerald Spöttl; Julian Maurer; Christoph Auernhammer
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

5.  Low Serum Carotenoids Are Associated with Self-Reported Cognitive Dysfunction and Inflammatory Markers in Breast Cancer Survivors.

Authors:  Krystle E Zuniga; Nancy E Moran
Journal:  Nutrients       Date:  2018-08-17       Impact factor: 5.717

Review 6.  A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy.

Authors:  Min Woo Kim; Seung-Hae Kwon; Jung Hoon Choi; Aeju Lee
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

7.  Hydroxytyrosol Supplementation Modifies Plasma Levels of Tissue Inhibitor of Metallopeptidase 1 in Women with Breast Cancer.

Authors:  Cesar Ramirez-Tortosa; Ana Sanchez; Cristina Perez-Ramirez; Jose Luis Quiles; María Robles-Almazan; Mario Pulido-Moran; Pedro Sanchez-Rovira; MCarmen Ramirez-Tortosa
Journal:  Antioxidants (Basel)       Date:  2019-09-11

8.  Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Cancers.

Authors:  Zhen Ye; Huanhuan Zhang; Fanhua Kong; Jing Lan; Shuying Yi; Wenshuang Jia; Shu Zheng; Yuna Guo; Xianquan Zhan
Journal:  Oxid Med Cell Longev       Date:  2021-12-20       Impact factor: 6.543

Review 9.  Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies.

Authors:  Anna Maria Mileo; Stefania Miccadei
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

10.  An exposure to the oxidized DNA enhances both instability of genome and survival in cancer cells.

Authors:  Svetlana V Kostyuk; Marina S Konkova; Elizaveta S Ershova; Anna J Alekseeva; Tatiana D Smirnova; Sergey V Stukalov; Ekaterina A Kozhina; Nadezda V Shilova; Tatiana V Zolotukhina; Zhanna G Markova; Vera L Izhevskaya; Ancha Baranova; Natalia N Veiko
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.